Filter News
Area of Research
- (-) Advanced Manufacturing (1)
- (-) Neutron Science (24)
- (-) Nuclear Science and Technology (6)
- Biology and Environment (35)
- Clean Energy (30)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Energy Frontier Research Centers (1)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Fusion Energy (1)
- Isotopes (24)
- Materials (55)
- Materials for Computing (11)
- National Security (16)
- Quantum information Science (1)
- Supercomputing (66)
News Topics
- (-) Coronavirus (9)
- (-) Isotopes (5)
- (-) Machine Learning (4)
- (-) Nanotechnology (10)
- (-) Summit (6)
- 3-D Printing/Advanced Manufacturing (29)
- Advanced Reactors (12)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (8)
- Biology (5)
- Biomedical (13)
- Biotechnology (1)
- Chemical Sciences (2)
- Clean Water (2)
- Climate Change (1)
- Composites (4)
- Computer Science (16)
- Cybersecurity (3)
- Decarbonization (3)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (10)
- High-Performance Computing (2)
- Materials (18)
- Materials Science (30)
- Mathematics (1)
- Microscopy (3)
- Molten Salt (4)
- National Security (2)
- Neutron Science (101)
- Nuclear Energy (39)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (9)
- Sustainable Energy (8)
- Transformational Challenge Reactor (4)
- Transportation (5)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.